Trial Profile
Registrational phase II/III trial of long-acting C-peptide (CBX129801) in patients with diabetic peripheral neuropathy.
Status:
Recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 12 Jun 2012
Price :
$35
*
At a glance
- Drugs C-peptide (Primary)
- Indications Diabetic neuropathies
- Focus Registrational; Therapeutic Use
- 01 Jun 2012 Status changed from not yet recruiting to recruiting (the phase II portion of the trial is underway).
- 25 Jun 2011 New trial record